Barrier Therapeutics to Present at the Roth Capital Partners New York Conference.PRINCETON, N.J. -- Barrier Therapeutics, Inc. (Nasdaq:BTRX), a biopharmaceutical company developing pharmaceutical products in the field of dermatology, today announced that Dr. Geert Cauwenbergh, Chairman and Chief Executive Officer of Barrier Therapeutics, is scheduled to provide an update to the investment community on the Company at the Roth Capital Partners Roth Capital Partners, LLC, is a full service Investment Banking firm, specializing in the small and micro cap markets. Roth’s focus, according to its official website, "has been, is, and will continue to be providing the full spectrum of investment banking services, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of Conference on Monday, September 13th, at 2:30 pm, eastern time. Dr. Cauwenbergh's presentation will also be available live via a webcast that can be accessed through the Company's website: www.barriertherapeutics.com About Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative pharmaceutical products to treat diseases of the skin. The Company has eight product candidates in various stages of clinical development. The four most advanced product candidates, which are in or entering Phase III clinical trials, are under development for the treatment of Candida-associated diaper dermatitis di·a·per dermatitis n. A form of dermatitis occurring where a diaper makes contact with the skin and caused by exposure to feces and urine and possibly by the ammonia produced by decomposing urine; diaper rash. Also called diaper rash. , seborrheic dermatitis, fungal infections, including vaginal candidiasis and onychomycosis, and congenital ichthyosis Ichthyosis Definition Derived from two Greek words meaning "fish" and "disease," ichthyosis is a congenital (meaning present at birth) dermatological (skin) disease that is represented by thick, scaly skin. . Barrier has product candidates in earlier stages of clinical development for the treatment of acne, psoriasis, fungal infections, allergies and dermatitis. The Company is headquartered in Princeton, New Jersey
Princeton, New Jersey is located in Mercer County, New Jersey, United States. Princeton University has been sited in the town since 1756. , and has a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. in Geel, Belgium. Website: www.barriertherapeutics.com About the Roth Capital Partners New York Conference This annual event is the largest in the nation for emerging growth companies. It provides a concentrated forum where Institutional Investors can meet the executives of growth companies hand picked by Roth Capital's research team. The conference will highlight approximately 225 companies from industry groups including Health Care/Life Sciences; Consumer Products; Defense & Industrial Technologies; Digital Media, IT & Entertainment; Broadband & Fiber Optics; Gaming; and Business and Banking/Financial Services. This year, as a result of numerous client requests, Roth has extended the conference to three working days, including a Discovery Day, which will be hosted by RedChip Resources, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control . For more information about the conference, visit: http://www.rothcp.com/Conf%20NY%20Web%20Site/Roth.htm?content=home. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion